Skip to main content

Table 3 Maternal characteristics for Normal vs Low PlGF values in the Extension data, (n (%) or median (interquartile range))

From: Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters

Characteristics

Low PlGF

(<  100 pg/ml),

n (%) or median (IQR),

(n = 485)

Normal PlGF

(≥100 pg/ml),

n (%) or median (IQR),

(n = 56)

DEMOGRAPHICS & PREGNANCY CHARATERISTICS

 Maternal age at EDD (year)

30 [24, 34]

29 [26, 34]

 Parity ≥ 1

192 (39.6%)

27 (48.2%)

 Gestational age at eligibility (week)

32.6 [29.6, 35.7]

35.2 [33.4, 36.8]

 Gestational age at eligibility < 35 weeks, N

329 (67.8%)

26 (46.4%)

 Multiple pregnancy

40 (8.2%)

3 (5.4%)

 Smoking in this pregnancy

101 (20.8%)

17 (30.4%)

CLINICAL MEASURES

 Systolic BP (mm Hg)

144 [135, 155]

136 [126, 150]

 Diastolic BP (mm Hg)

86 [78, 94]

80 [74, 91]

 Uric acid

375 [315, 435]

297 [256, 351]

 Lowest platelet count (× 109 per L)

199 [154, 243]

226 [160, 251]

 Highest AST/ALT (U/L)

24 [19, 37]

18 [16, 24]

 Creatinine

62 [53, 71]

53 [44, 62]

INTERVENTIONS DURING ADMISSION

 Corticosteroids, GA onset < 35

127/329 (38.6%)

7/26 (26.9%)

 Antihypertensive therapy

348 (71.8%)

36 (64.3%)

 MgSO4

376 (77.5%)

34 (60.7%)

PREGNANCY OUTCOMES

 Admission-To-Delivery Interval (Days)

2 [1, 4]

2 [1, 7]

 Gestational age at delivery (week)

33.3 [30·1, 36.3]

36.1 [34.7, 37.3]

 Stillbirth

10 (2.1%)

0

 Neonatal death

12 (2.5%)

0

MATERNAL OUTCOME (N women)

 Within 48 h

41 (8.5%)

3 (5.4%)

 Within 7 days

49 (10.1%)

3 (5.4%)

 At anytime

53 (10.9%)

4 (7.1%)

PlGF measurement-To-adverse maternal outcome Interval (at any time, Days)

3 [2, 6]

Mean = 4

3 [1, 5]

Mean = 2

  1. Abbreviations: AST (aspartate aminotransferase), BP (blood pressure), EDD (estimated date of delivery), MgSO4 (magnesium sulphate)